Women with or at high risk for HIV infection can continue to use all hormonal contraceptive methods without restriction.
In an update to the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 (World Health Organization [WHO] MEC), the CDC has reevaluated the evidence about hormonal contraceptive use — including combination and progestin-only pills, injections, and implants — and risk for HIV acquisition, transmission, and disease progression in women with or at high risk for HIV. Overall, the CDC affirmed that hormonal contraception is safe, given that evidence of harm is lacking or inconsistent. However, the updated recommendations include a clarification that high-risk women who use progestin-only injections might be at excess risk for HIV acquisition and should use condoms. These guidelines are consistent with the WHO's recent statement on hormo…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)